Emcure Pharma share surge 6 percent after healthy Q2 earnings show - Moneycontrol

EMCURE Stock   1,421  33.45  2.41%   
About 55% of Emcure Pharmaceuticals' investors are presently thinking to get in. The analysis of the overall prospects from investing in Emcure Pharmaceuticals suggests that some traders are, at the present time, interested. The current market sentiment, together with Emcure Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Emcure Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Emcure Pharma share surge 6 percent after healthy Q2 earnings show Moneycontrol

Read at news.google.com
Google News at Macroaxis
  

Emcure Pharmaceuticals Fundamental Analysis

We analyze Emcure Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emcure Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emcure Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Emcure Pharmaceuticals is rated below average in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Emcure Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Emcure Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Emcure Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Emcure Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Emcure Pharmaceuticals Related Equities

DELTAMAGNTDelta Manufacturing   8.07   
0%
100.0%
COSMOFIRSTCOSMO FIRST   4.00   
0%
49.0%
EMCUREEmcure Pharmaceuticals   2.41   
0%
29.0%
KINGFAKingfa Science   0.58   
0%
7.0%
TBZTribhovandas Bhimji   0.38   
0%
4.0%
AKUMSAkums Drugs   0.33   
4.0%
0%
RICOAUTORico Auto   0.81   
10.0%
0%
INNOVACAPInnova Captab   1.15   
14.0%
0%
PARAGMILKParag Milk   1.73   
21.0%
0%
GATECHDVRGACM Technologies   2.08   
25.0%
0%

Complementary Tools for Emcure Stock analysis

When running Emcure Pharmaceuticals' price analysis, check to measure Emcure Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emcure Pharmaceuticals is operating at the current time. Most of Emcure Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Emcure Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emcure Pharmaceuticals' price. Additionally, you may evaluate how the addition of Emcure Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk